7/22/2011

Belgian Omega Pharma in search of Turkish drugmakers to acquire

/Style%20Library/Invest/images/news.png
Star - Belgian non-prescription drugs producer Omega Pharma intends to expand its presence in the Turkish market by acquiring local companies, Vice President Chris Staeuble has said. “Omega Pharma is set to grow in Türkiye and Poland regardless of its current market share,” said Staeuble in a press meeting in Istanbul.

“We are actively looking for acquisition opportunities in Türkiye,” said Staeuble, lauding Türkiye’s high-performing economy and growing healthcare sector. “Türkiye is one of the most promising countries when it comes to healthcare investments. Omega Pharma plans to acquire local players to grab a larger market share in Türkiye’s over-the-counter (OTC) drugs,” he added.

Omega Pharma markets over 50 OTC drugs under 10 different brands in Türkiye. The company has operations in 35 countries.

Explore Türkiye's Strategic Investment Ecosystem

Powerhouse

Türkiye is the Global Powerhouse for Investments.

Discover Now

FDI Strategy

Access Türkiye's roadmap for high-quality FDI.

View Now

Start in Türkiye

Explore funding opportunities in Türkiye.

View Now

FDI Glossary

Unlock key FDI concepts and policies.

Discover Now